Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:14 PM
Ignite Modification Date:
2025-12-24 @ 1:14 PM
NCT ID:
NCT01474395
Eligibility Criteria:
Inclusion Criteria:
* 18 to 64 years old, IQ≥85 and estimated Glomerular Filtration Rate (GFR) \< or =60. All oral and depot antipsychotics (with the exception of clozapine) are allowable.
* Patients must be on their antipsychotic medication for 1 month and stable on dose of antipsychotic and adjunctive medications for 2 weeks prior to study entry.
Exclusion Criteria:
* Include a history of neurological visual or hearing impairment, active suicidal ideation on the Calgary Depression Scale (CDS), current alcohol or drug abuse (\<1 month) or substance dependence (\<4 months).
* All women of child-bearing potential must have a negative serum pregnancy test at the baseline visit.
* We require an IQ of greater or equal to 85 to ensure that subjects will have a capacity to learn.
* In our cross-sectional studies, we have observed an IQ greater than 85 in over 90% of candidates, suggesting that this is not an overly restrictive criterion.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
64 Years
Study:
NCT01474395
Study Brief:
Protocol Section:
NCT01474395